Patents by Inventor Meemanage De Zoysa

Meemanage De Zoysa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION
    Publication number: 20240132890
    Abstract: The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 25, 2024
    Applicants: University of Rochester, ProQR Therapeutics II B.V.
    Inventors: Bart KLEIN, Janne Juha TURUNEN, Lenka VAN SINT FIET, Pedro Duarte Morais Fernandes Arantes DA SILVA, Julien Auguste Germain BOUDET, Yi-Tao YU, Hironori ADACHI, Meemanage De ZOYSA
  • Nucleic acid molecules for pseudouridylation
    Patent number: 11866702
    Abstract: The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: January 9, 2024
    Assignees: University of Rochester, ProQR Therapeutics II B.V.
    Inventors: Bart Klein, Janne Juha Turunen, Lenka Van Sint Fiet, Pedro Duarte Morais Fernandes Arantes Da Silva, Julien Auguste Germain Boudet, Yi-Tao Yu, Hironori Adachi, Meemanage De Zoysa
  • NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION
    Publication number: 20210010002
    Abstract: The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme.
    Type: Application
    Filed: March 27, 2019
    Publication date: January 14, 2021
    Inventors: Bart Klein, Janne Juha Turunen, Lenka Van Sint Fiet, Pedro Duarte Morais Fernandes Arantes Da Silva, Julien Auguste Germain Boudet, Yi-Tao Yu, Hironori Adachi, Meemanage De Zoysa